Cedar Wealth Management, LLC Biomarin Pharmaceutical Inc Transaction History

Cedar Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$71.48 - $86.85 $142 - $173	-2 Reduced 50.0%	2 $0
Q1 2022 May 12, 2022	SELL	$74.28 - $92.69 $297 - $370	-4 Reduced 50.0%	4 $0
Q4 2021 Feb 11, 2022	SELL	$71.72 - $91.47 $13,411 - $17,104	-187 Reduced 95.9%	8 $1,000
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $3,364 - $3,846	45 Added 30.0%	195 $15,000
Q2 2021 Aug 09, 2021	BUY	$75.51 - $84.79 $11,326 - $12,718	150 New	150 $13,000
Q4 2018 Jan 23, 2019	SELL	$80.14 - $106.07 $4,167 - $5,515	-52 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$76.01 - $99.03 $3,952 - $5,149	52 New	52 $5,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Cedar Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Wealth Management, LLC with notifications on news.